Urinary Tract Infections: Bacteriophages
Commons · Question 117213 · Tabled 2 Mar 2026 · Department of Health and Social Care · Official record
Answered 16 Mar 2026
Question
Asked by Allison Gardner
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of phage medicines on tackling (a) recurrent and chronic urinary tract infections and (b) associated antimicrobial resistance.
Answer
Answered by Sharon Hodgson, 16 Mar 2026
The Department recognises bacteriophage, or phage, medicines as a promising complementary option for difficult bacterial infections, including recurrent and chronic urinary tract infections (UTIs), and as a potential tool to address antimicrobial resistan...